Carlyn Tan

3.2k citations
60 papers · 1.3k indexed · h-index 15

Impact in

  • Oncology top 5%
    • CAR-T cell therapy research
    • Chemotherapy-related skin toxicity

Papers in

    • Multiple Myeloma Research and Treatments 28
    • CAR-T cell therapy research 11
    • Cancer Treatment and Pharmacology 6
    • Viral-associated cancers and disorders 3

Carlyn Tan

51 papers receiving 1.2k citations

Peers

Carlyn Tan
Comparison fields: 5 of 89
  • Oncology 533
  • Dermatology 151
  • Genetics 175
  • Hematology 170
  • Pathology and Forensic Medicine 258
Replace İbrahim Barışta with:
İbrahim Barışta Türkiye
Carlos Panizo Spain
Fadhela Bouafia France
Seongseok Yun United States
Isabelle Moullet France
Samantha Pozzi Italy
Jae Ho Han South Korea
Yacine Salhi United States
E. George Elias United States
C.J. van Groeningen Netherlands
Carlyn Tan relative to İbrahim Barışta Türkiye İbrahim Barışta's profile →
Citations per field
00.5×1.5×2.4×
İbrahim Barışta · 1×
Citations per year

Countries citing papers authored by Carlyn Tan

Since Specialization
Citations

This map shows the geographic impact of Carlyn Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlyn Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlyn Tan more than expected).

Fields of papers citing papers by Carlyn Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlyn Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlyn Tan. The network helps show where Carlyn Tan may publish in the future.

Co-authors

The 25 scholars most cited alongside Carlyn Tan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carlyn Tan Line = papers co-authored together Carlyn Tan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20240
3 20241
4 20240
5 20240
6 20248
7 20231
8 20231
9 20231
10 20231
11 20210
12 201990
13 2018114
14 20174
15 201653
16 201515
17 201487
18 20131
19 20041
20
Phase I study of chlorozotocin
19781

About Carlyn Tan

Carlyn Tan is a scholar working on Hematology, Oncology, Transplantation, Genetics and Dermatology, having authored 60 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (28 papers), CAR-T cell therapy research (11 papers), Protein Degradation and Inhibitors (8 papers), Cancer Treatment and Pharmacology (6 papers), Lymphoma Diagnosis and Treatment (5 papers), Chronic Lymphocytic Leukemia Research (3 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Oncology (533 citations), Dermatology (151 citations), Genetics (175 citations), Hematology (170 citations) and Pathology and Forensic Medicine (258 citations). Carlyn Tan has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include M. Lois Murphy, Gerald Rosen, Stefan K. Barta, Giulio J. D’Angio, William Cham, Saif Abdul-Majeed, Jeffrey C. Allen, Russell Walker, Mark T. Jennings and Andrew Hendifar. Their work appears in journals such as Blood, Journal of Clinical Oncology, Cancer, Journal of Pediatric Gastroenterology and Nutrition and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026